YOUR GUIDE TO PATIENT SUPPORT SERVICES

Similar documents
INFORMATION ABOUT THERAPY WITH ONIVYDE (irinotecan liposome injection)

A GUIDE TO STARTING TREATMENT

IPSEN CARES Enrollment Form

Treatment Journal. Therapy Tracker TREATMENT JOURNAL

PRODUCT INFORMATION 1 ABOUT THIS GUIDE DOSAGE FORM AND STRENGTH STORAGE AND HANDLING

Fuel your determination to live longer with KYPROLIS. Look inside to learn more.

IPSEN CARES Patient Assistance Program Application

YOUR CABOMETYX HANDBOOK

Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

was proven to help people live longer1 BLINCYTO A guide for patients and caregivers

What are my treatment support resources?

BLINCYTO can eliminate detectable traces of cancer 1

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Take on IPF progression with OFEV

You Have the Power to Take Action

Doctor Discussion Guide

LIVE LONGER. Chart a course that could help you. If multiple myeloma comes back:

AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.

ARIKAYCE IMPORTANT SAFETY INFORMATION

Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer

Does yours? Most school-age kids with asthma have allergic asthma. Enroll in our support program. Learn about this distinct condition


offers the possibility of a longer life 1 BLINCYTO A guide for patients and caregivers

Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA?

Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects

How SYLVANT May Help IMPORTANT SAFETY INFORMATION. Multicentric Castleman s Disease.

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE

How does my new treatment work?

LIVING PROOF. 23% Reduction in the risk of death compared with standardof-care. A guide to combination treatment with RYDAPT

EMBRACING TODAY TOGETHER. A Guide For Caregivers

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

PATIENT SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR PATIENTS. Before starting on Soliris Important safety information for patients

IMBRUVICA (ibrutinib) Your ally to help fight previously treated MCL

ONE PILL, ONCE A DAY GET TO KNOW AUBAGIO. Ask your doctor if AUBAGIO may be right for you. Patient Portrayal

One daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection.

ITS MATCH MAY HAVE MET YOUR METASTATIC COLORECTAL CANCER. What to expect during treatment with Vectibix. Important Safety Information.

A GUIDE TO TREATMENT WHILE TAKING RYDAPT FOR ADVANCED SM

Rick N. EMPLICITI patient Ready to get started

Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.

Getting started with PROMACTA (eltrombopag)

GAZYVA for Chronic Lymphocytic Leukemia (CLL)

Discussion guide. Questions to bring to your next doctor s appointment. Notes

PRESCRIBER SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR THE HEALTHCARE PROVIDER

What you need to know as you begin your treatment for symptomatic neurogenic orthostatic hypotension (noh)

Get an Insurance Benefits Review for ORENCIA (abatacept)

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use

Treating Adults with Cervical Dystonia

DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT

Before starting on Soliris.

Gemcitabine and Cisplatin

AVEED TESTOSTERONE INJECTION. Not an actual patient.

Randy J. EMPLICITI patient Ready to get started

KEEP LOVING. Because HIV doesn t change who you are.

Learning More Can Make a Difference

Giving appropriate patients another chance to fight OPDIVO

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

HOW TO USE. 75 mg capsules. and make the most out of your cutaneous T-cell lymphoma (CTCL) treatment

People who have received 1-3 prior treatments for their multiple myeloma may receive: Revlimid (lenalidomide)

MEDICATION GUIDE Myobloc (My-o-block) (rimabotulinumtoxinb) Injection

Patient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol. Do not use your ALVESCO Inhalation Aerosol near heat or an open flame.

Information for Veterans with ALS

A TREATMENT GUIDE FOR YOU

UNDERSTANDING POLYCYTHEMIA VERA (PV) A guide for patients and caregivers

GLEEVEC PATIENT RESOURCES

For the Patient: Bendamustine Other names: TREANDA

Life shouldn't take a back seat to plaque psoriasis.

For the Patient: USMAVFIPI

SAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA.

You matter and so does your health.

MEDICATION GUIDE. (tocilizumab)

The ORENCIA (abatacept) JIA Observational Registry

Watch Now! Hear real patients and experts. Search for our Facing CIU Channel.

How are unresolved Myasthenia Gravis symptoms disrupting your day? Talk to your doctor about your symptoms

Managing a UCD Video: Transcript. Ammonia. Urea. Liver graphic. RAVICTI logo

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

ITS MATCH MAY HAVE MET YOUR METASTATIC COLORECTAL CANCER. Important Safety Information. Indication and Limitation of Use. Your Doctor Discussion Guide

Take CYCLOSET exactly as instructed by your health care provider, and be sure to read the Patient Information section of the package insert.

HELPING LIFT YOU THROUGH YOUR JOURNEY WITH SYMPTOMATIC SARCOIDOSIS

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help

TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT.

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

PATIENT GUIDE. Highlights of Important Safety Information Warnings and Precautions. Your guide to treatment with Signifor LAR for acromegaly

FDA APPROVED MEDICATION GUIDE

Take the next step with Strensiq.

Everolimus (Afinitor )

GAZYVA: for follicular lymphoma that has not responded to or has returned after treatment

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet

ALECENSA (alectinib) Fact Sheet

She is scared sometimes, and so am I, but who wouldn t be? I am proud that we have never given up and never lost hope.

PART III: CONSUMER INFORMATION

TAFINLAR + MEKINIST. for more moments FOR PATIENTS WITH A CERTAIN TYPE OF BRAF+ ADVANCED MELANOMA

Could your uncontrollable movements be tardive dyskinesia (TD)?

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

QUESTIONS TO ASK MY DOCTOR

Medication Tracker for ZYTIGA (abiraterone acetate)

severe diarrhea? Do you have ZINPLAVA is a medicine that helps reduce the risk that your C diff will come back.

Transcription:

YOUR GUIDE TO PATIENT SUPPORT SERVICES Please see Important Safety Information About ONIVYDE (irinotecan liposome injection) on pages 6 7.

WHAT IS PROVYDE (ONIVYDE ACCESS SERVICES)? PROVYDE is a team of individuals established by Ipsen who can help you and your loved ones as you consider treatment with ONIVYDE (irinotecan liposome injection). HOW DO I GET STARTED? When you or your doctor submits the all-in-one Start Form, PROVYDE can assist you in a number of ways, including: Understanding your insurance coverage Researching available financial assistance options, and Providing useful information on additional support, including transportation assistance HOW WILL I KNOW IF MY INSURANCE COVERS TREATMENT WITH ONIVYDE? Coverage for ONIVYDE will vary by plan and by patient. PROVYDE can evaluate if your specific plan covers ONIVYDE and how much you will owe. $? WHAT FINANCIAL ASSISTANCE PROGRAMS DOES PROVYDE OFFER? PROVYDE can help you assess your eligibility for one of the 3 programs available: Free Drug Program Copay assistance - $0 copay program for commercially insured patients - Referrals to independent, nonprofit organizations 2 To determine your eligibility for financial assistance or for any other questions, please talk to your HCP or contact PROVYDE at 844-664-8933, 8am 8p m ET, Monday Friday.

? HOW DO I KNOW IF I M ELIGIBLE FOR ASSISTANCE? PROVYDE manages the free drug and $0 copay programs. See the table below for eligibility criteria. ELIGIBILITY CRITERIA Free Drug Program $0 Commercial Copay Program Uninsured/functionally uninsured* Commercially insured patients You are prescribed ONIVYDE for an FDA-approved indication You are prescribed ONIVYDE for an FDA-approved indication Treated in the US (including US territories) Treated in the US (including US territories) Meet income criteria * Functionally uninsured patients are those who may be enrolled in a health plan but do not have coverage for ONIVYDE. The commercial copay program is not available to patients covered by government-sponsored insurance such as Medicare and Medicaid. Please see Important Safety Information About ONIVYDE on pages 6 7. 3

IF I HAVE COMMERCIAL INSURANCE COVERAGE, CAN I GET HELP WITH MY COPAY? The $0 copay program helps individuals pay for their eligible out-of-pocket drug expenses, including copays, co-insurance, and deductibles. PROVYDE can help you and your doctor through the application process. $ IF I HAVE MEDICARE OR MEDICAID, CAN I GET HELP WITH MY COPAY? PROVYDE can refer you to an independent, nonprofit organization and help you and your doctor through the application process. IF I HAVE NO INSURANCE COVERAGE, CAN I STILL GET TREATMENT? If you do not have health insurance coverage or enough insurance to pay for ONIVYDE (irinotecan liposome injection), you may qualify for the Free Drug Program. PROVYDE can help you and your doctor through the application process. $ + WHAT OTHER TYPE OF ASSISTANCE IS AVAILABLE? The nonprofit organizations also provide travel assistance for qualified patients. The assistance can be applied to a wide range of transportation needs, eg, public transportation to and from your doctor s appointments (including subway, bus, train, and taxi), gas, parking, tolls, etc. 4

ADDITIONAL SUPPORT FOR YOU AND YOUR CAREGIVER PROVYDE can refer you and your caregiver to independent, nonprofit organizations that offer a range of resources to both patients and caregivers, such as: Counseling Free support groups Education workshops led by experts in oncology Free booklets and fact sheets with information about the latest cancer treatments, managing side effects, and coping with cancer NOTES Please see Important Safety Information About ONIVYDE on pages 6 7. 5

IMPORTANT SAFETY INFORMATION ABOUT ONIVYDE (IRINOTECAN LIPOSOME INJECTION) ONIVYDE can cause problems that can sometimes become serious or life threatening and can lead to death. Serious side effects may include fever and infection associated with a low white blood cell count (neutropenic fever, neutropenic sepsis); diarrhea; lung problems (interstitial lung disease, a group of diseases which cause inflammation of the lung tissues leading to scarring); and reactions during administration of ONIVYDE (including anaphylactic reactions). The most common side effects which were seen in people with pancreatic cancer treated with ONIVYDE include: diarrhea, feeling tired, vomiting, nausea, loss of appetite, inflammation in the mouth, fever, and dehydration. When taking ONIVYDE, you may also have abnormal blood test results. The most common blood cell count change seen in ONIVYDE-treated pancreatic cancer patients is a reduction in the number of white blood cells, specifically lower lymphocytes and neutrophils (types of white blood cells), which are important for fighting infections. Before you receive ONIVYDE, your healthcare provider will give you medications to decrease the potential for allergic reactions to infusion of ONIVYDE. You will also receive antinausea medicine to decrease nausea and vomiting, and, possibly, a medicine to decrease immediate diarrhea, called an anti-cholinergic. What is ONIVYDE used for? ONIVYDE is a prescription medicine used to treat pancreatic cancer which has spread to other parts of the body. ONIVYDE can be used in patients who have already received gemcitabine treatment for their pancreatic cancer. ONIVYDE is given in combination with 2 other medicines, fluorouracil (also known as 5-FU) and leucovorin (which is often abbreviated as LV), and is not given alone. When should ONIVYDE not be given? You should not receive ONIVYDE if: you have had a severe allergic reaction to ONIVYDE or irinotecan HCl, your white blood cell count is low (neutrophil white blood cell count below the level of 1,500 cells/mm 3 ), you have a fever and your neutrophil white blood cell count is low (also called neutropenic fever), or you have a problem in your bowel that prevents food, fluids or gas from moving through your intestines. Serious side effects may occur while taking ONIVYDE. Call or see your healthcare provider right away if you develop any of the following or if these get worse. Serious side effects may include: Infections (particularly if your white blood cells are low). Symptoms of infection may include fever, chills, dizziness, or shortness of breath. Blood cell counts will be monitored periodically by your healthcare provider during treatment. Diarrhea. Symptoms of severe diarrhea may include persistent diarrhea; discolored stools (black, green or bloody); or symptoms of dehydration such as lightheadedness, dizziness, or faintness. Your healthcare provider may treat diarrhea with anti-diarrhea medicines (loperamide or atropine). 6

IMPORTANT SAFETY INFORMATION ABOUT ONIVYDE (IRINOTECAN LIPOSOME INJECTION) CONT D Lung problems (interstitial lung disease). Symptoms of interstitial lung disease include new onset of cough or difficulty breathing and fever. Allergic reaction (hypersensitivity). Seek immediate medical attention for signs of severe reaction such as chest tightness; shortness of breath; wheezing; dizziness or faintness; or swelling of the face, eyelids, or lips when receiving or during the 24 hours after receiving ONIVYDE. Getting medical treatment right away may keep these problems from becoming more serious. Your healthcare provider will check you for these problems during treatment with ONIVYDE. Your healthcare provider may also need to delay or completely stop treatment with ONIVYDE, if you have severe side effects. The most frequent side effects resulting in discontinuation of ONIVYDE were diarrhea, vomiting, and infection caused by low white blood cells (neutropenic sepsis). The most frequent side effects requiring dose reductions of ONIVYDE were neutropenia, diarrhea, nausea, and low red blood cell count (anemia). The most frequent side effects requiring dose interruption or delays of ONIVYDE were neutropenia, diarrhea, fatigue, vomiting, and low platelet counts called thrombocytopenia (platelets are important for clotting to stop bleeding). Tell your healthcare provider about all the medicines you take, including: prescriptions over-the-counter medicines vitamins herbal supplements Pregnancy and Nursing: If you are a female, tell your healthcare provider if you are pregnant or plan to become pregnant. ONIVYDE can harm your unborn baby. Females who are able to become pregnant should use an effective method of birth control during and for at least 1 month after the last dose of ONIVYDE. Talk to your healthcare provider about birth control methods that you can use during this time. Tell your healthcare provider right away if you become pregnant during treatment with ONIVYDE. Before receiving ONIVYDE, tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if ONIVYDE passes into your breast milk. Do not breastfeed during treatment with ONIVYDE and for at least 1 month after the last dose of ONIVYDE. If you are a man, you should not father a child during your treatment with ONIVYDE. ONIVYDE can harm the unborn baby of your partner. You should use an effective method of birth control during and for at least 4 months after the last dose of ONIVYDE. These are not all the possible side effects of ONIVYDE. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. To learn more, talk to your healthcare provider. You can ask your doctor or pharmacist for information about ONIVYDE that is written for health professionals, and it can be found at ONIVYDE.com. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Safety Information About ONIVYDE on pages 6 7. 7

FIND ANSWERS TO THE FOLLOWING QUESTIONS INSIDE THIS BROCHURE: What is PROVYDE (ONIVYDE Access Services)? How do I get started? How will I know if my insurance covers treatment with ONIVYDE (irinotecan liposome injection)? What financial assistance programs does PROVYDE offer? How do I know if I m eligible for assistance? If I have commercial insurance coverage, can I get help with my copay? If I have Medicare or Medicaid, can I get help with my copay? If I have no insurance coverage, can I still get treatment? What other type of assistance is available? To learn more about PROVYDE, visit ONIVYDE.com. ONIVYDE is a registered trademark of Ipsen Biopharm Ltd. Please see Important Safety Information About ONIVYDE on pages 6 7. 2017 Ipsen Biopharmaceuticals, Inc. All rights reserved. April 2017 ONV-US-000088 Hours: 8am 8pm ET, Monday Friday Phone: 844-ONIVYDE (664-8933) Fax: 844-269-3039 Mail: PO Box 4133, Gaithersburg, MD 20885-4133